Imago BioSciences is Drug Discovery in United States that focus on Imago BioSciences Inc business. Founded in 2012. They cover business area such as Imago BioSciences Inc, novel small molecule product candidate, an enzyme, blood cell, length, life, patient, cancer and bone marrow disease, Bomedemstat, an orally available, small molecule inhibitor, MPNs, related, chronic cancer, essential thrombocythemia, (ET, myelofibrosis, MF.
2012
( 12 years old in 2024 )
Imago BioSciences Inc
-
329 Oyster Point Boulevard
3rd Floor
South San Francisco, CA 94080
United States
Private
Imago BioSciences Incnovel small molecule product candidatean enzymeblood celllengthlifepatientcancer and bone marrow diseaseBomedemstatan orally available, small molecule inhibitorMPNsrelated, chronic canceressential thrombocythemia(ETmyelofibrosisMF
* We use standard office opening hours in near Imago BioSciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Imago BioSciences is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), Imago BioSciences business is focusing on Imago BioSciences Inc.
Imago BioSciences headquarter office and corporate office address is located in 329 Oyster Point Boulevard 3rd Floor South San Francisco, CA 94080 United States.
Imago BioSciences was founded in United States.
In 2024, Imago BioSciences is currently focus on Imago BioSciences Inc sector.
Above is snippet of Google Trends for "Imago BioSciences Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Imago BioSciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
